This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Earnings Preview: Carlisle (CSL) Q1 Earnings Expected to Decline
by Zacks Equity Research
Carlisle (CSL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
When Does Market Timing Actually Work? - April 14, 2020
by Zacks Equity Research
In the long-run, does consistent market timing really matter to be a successful investor?
Yes, You Can Time the Market. Find out How - March 20, 2020
by Zacks Equity Research
In the long-run, does consistent market timing really matter to be a successful investor?
Why Is Carlisle (CSL) Down 10.4% Since Last Earnings Report?
by Zacks Equity Research
Carlisle (CSL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
The Truth About Market Timing - March 02, 2020
by Zacks Equity Research
In the long-run, does consistent market timing really matter to be a successful investor?
Crane (CR) to Benefit From Buyouts Amid Core Sales Headwinds
by Zacks Equity Research
Crane (CR) to gain from acquired assets, product development, repositioning initiatives and shareholder-friendly policies. Weakness in Engineered Materials and Aerospace & Electronics segments are dragging.
Carlisle Prices Notes Offering, to Repay Debts With Proceeds
by Zacks Equity Research
Carlisle (CSL) prices $750 million worth of senior notes offerings. The proceeds will likely be used for the redemption of existing senior notes and general corporate purposes.
Carlisle (CSL) Q4 Earnings & Revenues Surpass Estimates
by Zacks Equity Research
Carlisle's (CSL) fourth-quarter 2019 results reflect benefits from acquired assets and margin improvement.
The Truth About Market Timing - February 07, 2020
by Zacks Equity Research
In the long-run, does consistent market timing really matter to be a successful investor?
Carlisle (CSL) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Carlisle (CSL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Will Ailing Power Segment Continue to Hurt GE in Q4 Earnings?
by Zacks Equity Research
General Electric's (GE) Power segment's fourth-quarter results are likely to reflect the adverse impacts of prevailing internal and external challenges. Initiatives to restructure the power portfolio might have benefitted.
Will Aviation and Renewable Energy Benefit GE in Q4 Earnings?
by Zacks Equity Research
General Electric's (GE) Aviation segment's fourth-quarter results are expected to reflect gains from solid demand for LEAP engine. Healthy onshore business might have aided Renewable Energy.
Carlisle (CSL) Hit by Escalating Costs and CFT Challenges
by Zacks Equity Research
Surging costs, high debt level and ongoing challenges within the CFT segment are thwarting Carlisle Companies' (CSL) growth.
The Market Timing Secrets No One Talks About - December 30, 2019
by Zacks Equity Research
Have you ever dreamed of being that one in a million investor who has the talent to perfectly time the markets?
The Market Timing Secrets No One Talks About - December 10, 2019
by Zacks Equity Research
Have you ever dreamed of being that one in a million investor who has the talent to perfectly time the markets?
Here is Why Growth Investors Should Buy Carlisle (CSL) Now
by Zacks Equity Research
Carlisle (CSL) could produce exceptional returns because of its solid growth attributes.
ITT (ITT) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
ITT (ITT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Here's Why it is Worth Investing in Carlisle (CSL) Stock Now
by Zacks Equity Research
Carlisle (CSL) is likely to gain from strong North America non-residential construction market, focus on the medical technologies platform, shareholder-friendly policies and acquired assets.
Carlisle (CSL) Acquires Providien, Strengthens CIT Segment
by Zacks Equity Research
Carlisle's (CSL) buyout of Providien is expected to expand CIT segment's product portfolio for medical markets.
Why Is Carlisle (CSL) Up 3.2% Since Last Earnings Report?
by Zacks Equity Research
Carlisle (CSL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Carlisle (CSL) Upgraded to Buy: Here's Why
by Zacks Equity Research
Carlisle (CSL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Simple Market Timing Strategies That Work - November 19, 2019
by Zacks Equity Research
Have you ever dreamed of being that one in a million investor who has the talent to perfectly time the markets?
General Electric Arm Clinches Wind Turbine Deals From ENGIE
by Zacks Equity Research
General Electric's (GE) advanced 2 MW turbines will help ENGIE North America in providing clean and renewable energy in Oklahoma and South Dakota.
Carlisle (CSL) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Carlisle (CSL) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
3 Reasons Growth Investors Will Love Carlisle (CSL)
by Zacks Equity Research
Carlisle (CSL) possesses solid growth attributes, which could help it handily outperform the market.